| Literature DB >> 25705404 |
Tomoyuki Endo1, Shigeki Kushimoto2, Satoshi Yamanouchi2, Teruo Sakamoto3, Hiroyasu Ishikura4, Yasuhide Kitazawa5, Yasuhiko Taira6, Kazuo Okuchi7, Takashi Tagami8, Akihiro Watanabe8, Junko Yamaguchi9, Kazuhide Yoshikawa10, Manabu Sugita11, Yoichi Kase12, Takashi Kanemura13, Hiroyuki Takahashi14, Yuuichi Kuroki15, Hiroo Izumino16, Hiroshi Rinka17, Ryutarou Seo18, Makoto Takatori19, Tadashi Kaneko20, Toshiaki Nakamura21, Takayuki Irahara22, Nobuyuki Saito23.
Abstract
BACKGROUND: In patients with severe sepsis, depression of cardiac performance is common and is often associated with left ventricular (LV) dilatation to maintain stroke volume. Although it is essential to optimize cardiac preload to maintain tissue perfusion in patients with severe sepsis, the optimal preload remains unknown. This study aimed to evaluate the reliability of global end-diastolic volume index (GEDI) as a parameter of cardiac preload in the early phase of severe sepsis.Entities:
Keywords: Diastolic dysfunction; Global end-diastolic volume index; Sepsis-induced myocardial dysfunction; Severe sepsis; Stroke volume variation
Year: 2013 PMID: 25705404 PMCID: PMC4336275 DOI: 10.1186/2052-0492-1-11
Source DB: PubMed Journal: J Intensive Care ISSN: 2052-0492
Characteristics of patients with ALI/ARDS secondary to sepsis on the day of enrollment
| Characteristics | SIMD group | Non-SIMD group |
|
|---|---|---|---|
|
|
| ||
| Age, years | 79 (64–83) | 72 (62–82) | 0.430 |
| Gender (male), | 15 (65.2) | 42 (60.0) | 0.806 |
| Septic shock, | 14 (60.9) | 40 (57.1) | 0.899 |
| Vasoactive-inotropic agents, | 21 (91.3) | 50 (71.4) | 0.087 |
| APACHE II score, points | 24 (19–27) | 25 (19–30) | 0.565 |
| SOFA score, points | 12 (10–14) | 11 (9–13) | 0.345 |
| PaO2/FIO2 ratio, mmHg | 128 (80–198) | 134 (96–185) | 0.943 |
| GEDI, mL/m2 | 757 (644–892) | 837 (669–934) | 0.293 |
| EVLWi, mL/kg | 16.2 (13.2–21.5) | 18.2 (14.2–23.6) | 0.287 |
| PVPI | 2.9 (2.4–3.7) | 3.1 (2.4–3.9) | 0.599 |
| 28-day mortality, | 9 (39.1) | 32 (45.7) | 0.635 |
All data are presented as median (interquartile range) unless otherwise stated. ALI/ARDS acute lung injury/acute respiratory distress syndrome, APACHE Acute Physiology and Chronic Health Evaluation, SIMD sepsis-induced myocardial dysfunction, SOFA Sequential Organ Failure Assessment, GEDI global end-diastolic volume index, EVLWi extravascular lung water index, PVPI pulmonary vascular permeability index.
Figure 1Relationship between SVV and GEDI on the day of enrollment (day 0). There was a moderate positive correlation (r = 0.421, p = 0.045) between GEDI and SVV in the SIMD group, whereas no such correlation was noted in the non-SIMD group (r = −0.081, p = 0.503). SIMD, sepsis-induced myocardial dysfunction; GEDI, global end-diastolic volume index; SVV, stroke volume variation.
Figure 2Relationship between SVV and GEDI on day 2. There were no correlations between GEDI and SVV in both groups (SIMD group: r = −0.148, p = 0.557; non-SIMD group: r = −0.083, p = 0.545). SIMD, sepsis-induced myocardial dysfunction; GEDI, global end-diastolic volume index; SVV, stroke volume variation.
Figure 3Comparison of GEDI between patients with SVV ≤13% and SVV >13% on day 0. Among patients with the SIMD group, GEDI was significantly higher in patients with SVV >13% than in patients with SVV ≤13% on the day of enrollment (SVV >13%, 872 [785–996] mL/m2; SVV ≤13%, 640 [597–696] mL/m2; p < 0.001). In contrast, GEDI was not significantly different between patients with SVV ≤13% and SVV >13% in the non-SIMD group on the day of enrollment (SVV ≤13%, 852 [687–934] mL/m2; SVV >13%, 787 [620–998] mL/m2; p = 0.629). SIMD, sepsis-induced myocardial dysfunction; GEDI, global end-diastolic volume index; SVV, stroke volume variation.
Figure 4Comparison of GEDI between patients with SVV ≤13% and SVV >13% on day 2. On day 2, in both the SIMD and non-SIMD groups, there were no significant differences in the levels of GEDI between patients with SVV ≤13% and SVV >13% (SIMD with SVV ≤13%, 881 [784–1,001] mL/m2 vs. SIMD with SVV >13%, 811 [724–1,062] mL/m2, p = 0.722; non-SIMD with SVV ≤13%, 853 [754–1,170] mL/m2 vs. non-SIMD with SVV >13%, 795 [730–1,007] mL/m2, p = 0.289). SIMD, sepsis-induced myocardial dysfunction; GEDI, global end-diastolic volume index; SVV, stroke volume variation.